ConvaTec Group PLC (LON:CTEC - Get Free Report) shares hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 293.60 ($3.71) and last traded at GBX 289.20 ($3.65), with a volume of 5216740 shares changing hands. The stock had previously closed at GBX 289.60 ($3.66).
Analysts Set New Price Targets
CTEC has been the subject of several analyst reports. JPMorgan Chase & Co. increased their price objective on ConvaTec Group from GBX 300 ($3.79) to GBX 323 ($4.08) and gave the company an "overweight" rating in a report on Thursday, March 7th. Berenberg Bank increased their price objective on ConvaTec Group from GBX 290 ($3.66) to GBX 310 ($3.92) and gave the company a "buy" rating in a report on Wednesday, March 6th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of GBX 307.17 ($3.88).
View Our Latest Stock Report on CTEC
ConvaTec Group Price Performance
The company has a current ratio of 1.62, a quick ratio of 0.96 and a debt-to-equity ratio of 77.59. The stock has a market capitalization of £5.87 billion, a price-to-earnings ratio of 5,728.00, a PEG ratio of 2.59 and a beta of 0.55. The stock has a 50-day moving average price of GBX 257.08 and a 200 day moving average price of GBX 235.51.
ConvaTec Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Thursday, May 23rd. Investors of record on Thursday, April 25th will be issued a $0.04 dividend. This represents a yield of 1.39%. This is a boost from ConvaTec Group's previous dividend of $0.02. The ex-dividend date of this dividend is Thursday, April 25th. ConvaTec Group's payout ratio is presently 10,000.00%.
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Further Reading
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
